The international surgical journal with global reach

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2020; 69: 859–867.

Published: 15th October 2020

Authors: El-Salhy M, Hatlebakk JG, Gilja OH, Kristoffersen AB, Hausken T


Some 165 patients were randomized to a placebo, or one of two groups with different amounts of microbiota. A 50-point reduction in IBS score was recorded in 23.6 per cent of controls, versus 76.9 per cent in patients who had 30g microbiota and 89.1 per cent who had 60g (both P<0.001).

Pubmed Link